Therefore, reduction of TTC39B and enhancement of the LXRα-ABCA1/ABCG5/8 pathway was at least partly responsible for the inhibitory effect of EGCG on the anti-inflammatory and lipid-regulatory effects in high-fat-induced atherosclerosis. This evidence concerns the gene NR1H3 and atherosclerosis.